Chaspierre Holding SRL
Chaspierre Holding reported total assets of €1.13m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Chaspierre Holding shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Chaspierre Holding's annual accounts
| 2025 | |
|---|---|
| Net result | 34,649 € |
| Equity | 43,816 € |
| Cash | 25,181 € |
| Total assets | €1.13m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
Chaspierre Holding's financial analysis
- Solvency3.9%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Chaspierre Holding
Chaspierre Holding's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1019.183.255
- VAT number
- BE1019183255
- Peppol
- Registered · 0208:1019183255 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Jan 2025
- Registered office
- 4800 Verviers
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Chaspierre Holding (SRL) has been based in Verviers since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 34,649 € and equity of 43,816 €; its revenue is not published. Its solvency stands at 3.9%, below the median of its sector (40.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Chaspierre Holding
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Farma Noord Retail sale of pharmaceutical products Kalmthout · balance sheet €1.12m
- Deltaphar Retail sale of pharmaceutical products Auderghem · balance sheet €1.14m
- POP Pharma Retail sale of pharmaceutical products Ternat · balance sheet €1.14m
- Novaka Pharma Retail sale of pharmaceutical products Nivelles · balance sheet €1.10m
- Apoteek Mommaert Retail sale of pharmaceutical products Beersel · balance sheet €1.09m
- Bouckaert - Mekeirele Retail sale of pharmaceutical products Zedelgem · balance sheet €1.25m
- Capavita Retail sale of pharmaceutical products Schoten · balance sheet €1.09m
Frequently asked questions about Chaspierre Holding
What is the revenue of Chaspierre Holding?
Chaspierre Holding files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Chaspierre Holding?
In Belgium, the VAT number is the company number prefixed with BE: BE1019183255 for Chaspierre Holding, if the company is VAT-registered. Its company number (CBE) is 1019.183.255.
Where is the registered office of Chaspierre Holding?
According to the CBE register, the registered office of Chaspierre Holding is in 4800 Verviers.
What is the equity of Chaspierre Holding?
At the close of the 2025 financial year, the equity of Chaspierre Holding amounts to 43,816 €, a solvency of 3.9% of total assets.
Who manages Chaspierre Holding?
The register lists 1 active mandates at Chaspierre Holding. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Chaspierre Holding
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →